R. M. Sanghavi, T. A. Pana, H. Mamayusupova, I. Maidment, C. Fox, S. M. Boekholdt, M. A. Mamas, N. J. Wareham, K. Khaw and P. K. Myint. Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC-Norfolk prospective population-based cohort study. British Journal of Clinical Pharmacology, 2021 (under review). ID: EJEP-D-21-00558
C. Fleetwood, M. Salehi, R. Ward, H. Mamayusupova, A. Secchi, S. Coulton, I. D. Maidment, P. K. Myint, C. Fox and S. Sami. A data driven approach to anticholinergic burden quantification. Artificial Intelligence in Medicine, 2021 (under review)
H. Mamayusupova, M. Tolia, A.Secchi, M. Salehi, J. Cartwright, R. Ward, C. Skeen, S. Sami, I. D. Maidment, P. K. Myint, S. Coulton and C. Fox. Systematic review and narrative synthesis of antipsychotic drugs with anticholinergic effect on immune and metabolic biomarkers. Neuropsychopharmacology (manuscript in preparation).
H. Mamayusupova, D. Azman, V. Balakrishnan, S. Shamsuddin, P. Laissue, S. Kang, I. Chernukhin, D. Loukinov, V. Lobanenkov, V. B. Teif and E. Klenova. Disrupting the interaction of CTCF and RNA Polymerase II affects chromatin distribution, cell survival and proliferation, transcription and insulator function (in preparation).
G.J. Thorn, C. T. Clarkson, A. Rademacher, H. Mamayusupova, G. Schotta, K. Rippe and V.B. Teif. DNA sequence-dependent formation of heterochromatin nanodomains. bioRxiv 2020.12.20.423673; doi: https://doi.org/10.1101/2020.12.20.423673. Nature Genetics (under review).
C. T. Clarkson, E. A. Deeks, R. Samarista, H. Mamayusupova, V. B. Zhurkin and V.B. Teif. CTCF-dependent chromatin boundaries formed by asymmetric nucleosome arrays with decreased linker length. Nucleic Acids Research, 47, 11181–11196.